Frequency and prognosis of HER2-low status in Mexican patients with metastatic breast cancer

被引：1
|
作者：
Martinez-Cannon, Bertha Alejandra
Verduzco-Aguirre, Haydee Cristina
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-05-58
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-05-58
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
    Horisawa, Nanae
    Adachi, Yayoi
    Takatsuka, Daiki
    Nozawa, Kazuki
    Endo, Yuka
    Ozaki, Yuri
    Sugino, Kayoko
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    BREAST CANCER, 2022, 29 (02) : 234 - 241
  • [2] The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
    Nanae Horisawa
    Yayoi Adachi
    Daiki Takatsuka
    Kazuki Nozawa
    Yuka Endo
    Yuri Ozaki
    Kayoko Sugino
    Ayumi Kataoka
    Haruru Kotani
    Akiyo Yoshimura
    Masaya Hattori
    Masataka Sawaki
    Hiroji Iwata
    Breast Cancer, 2022, 29 : 234 - 241
  • [3] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Xin Yang
    Yao Li
    Xu lu
    Xiaotian Ren
    Bin Hua
    BMC Cancer, 23 (1)
  • [4] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Yang, Xin
    Li, Yao
    Lu, Xu
    Ren, Xiaotian
    Hua, Bin
    BMC CANCER, 2023, 23 (01)
  • [5] HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
    Agostinetto, Elisa
    Rediti, Mattia
    Fimereli, Danai
    Debien, Veronique
    Piccart, Martine
    Aftimos, Philippe
    Sotiriou, Christos
    de Azambuja, Evandro
    CANCERS, 2021, 13 (11)
  • [6] Determination of HER2-low status in tumors of patients with unresectable and/or metastatic breast cancer in DESTINY-Breast04
    Prat, Aleix
    Modi, Shanu
    Tsurutani, Junji
    Cameron, David
    Harbeck, Nadia
    Garrido, Charo
    Karnoub, Maha
    Hsu, Ching
    Feng, Wenquin
    Yung, Lotus
    Wang, Yibin
    Gambhire, Dhiraj
    Ford, Shirin K.
    Vitazka, Patrik
    Ueno, Naoto T.
    CANCER RESEARCH, 2023, 83 (05)
  • [7] Determination of HER2-Low Status in Tumors of Patients With Unresectable and/or Metastatic Breast Cancer in DESTINY-Breast04
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (02) : 8 - 9
  • [8] The impact of the HER2-low status on conditional survival in patients with breast cancer
    Ma, Teng
    Liu, Changgen
    Ma, Tianyi
    Sun, Xinyi
    Cui, Jian
    Wang, Lulu
    Mao, Yan
    Wang, Haibo
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [9] Frequency of HER2-Low in breast cancer biopsies in Chile
    Vidal, Martin
    Rivera, Alvaro
    Schuler, Constanza
    Garnham, Nicolas
    Alcalde, Elisa
    Renner, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Clinical presentations and prognosis of HER2-low breast cancer in Taiwan
    Chen, G. Y-J
    Hsu, C-Y
    Huang, C-C
    Tseng, L-M
    ANNALS OF ONCOLOGY, 2024, 35 : S283 - S284
12345